Global Piriformis Syndrome Market

Piriformis Syndrome Market size was valued at USD 286.35 Mn. in 2025 and the total revenue is expected to grow at a CAGR of 6.2% through 2026 to 2032, reaching nearly USD 435.71 Mn.

Piriformis Syndrome Market Overview:

Piriformis syndrome is a disorder in which the piriformis muscle in the buttocks spasms, causing pain in the buttocks. The neighbouring sciatic nerve can be irritated by the piriformis muscle, causing discomfort, numbness, and tingling down the back of the leg and into the foot (similar to sciatic pain). The pain associated with piriformis syndrome tends to intensify after prolonged sitting or physical activity such as walking. The majority of piriformis syndrome patients feel better after lying on their backs.To know about the Research Methodology :- Request Free Sample Report

Piriformis Syndrome Market Dynamics:

Piriformis syndrome is a severe neuromuscular disorder caused by compression of the sciatic nerve by the piriformis muscle. The piriformis muscle is a flat, band-like muscle found in the top part of the hip joint in the buttock. Piriformis syndrome is most common in adults and can affect people of all ages and levels of activity. Trauma, spasms, and overuse damage are the most prevalent causes of piriformis syndrome. The piriformis syndrome is also more common in patients with lower back discomfort, according to the National Center for Biotechnology Information (NCBI).

Stretching the piriformis muscle many times a day, particularly when paired with hamstring exercises, will avoid lower back tightness and release tension from hip to foot. The rising incidence of piriformis syndrome, more screening, rising safety and success of medication therapies, and the growing senior population are all driving the piriformis syndrome market. The complications of procedures, as well as a lack of information regarding the disease, are among the market limitations. Furthermore, difficulties in diagnosing the illness among the patient population is expected to limit the Piriformis Syndrome market growth during the forecast period.

Piriformis Syndrome Market Segment Analysis:

Based on the Cause, the market is segmented into Trauma, Spasms, Overuse injury, and others. Trauma segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2026-2032. A history of trauma, either a direct buttock contusion or a hip/lower back torsional injury, is found in around half of patients with piriformis syndrome. Because the remaining 50% of cases are of spontaneous onset, the treating physician must have a high index of suspicion.

Spasms segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2026-2032. A spasm is an involuntary contraction of a muscle, a set of muscles, or a hollow organ, such as the bladder, that occurs suddenly. Many medical diseases, including dystonia, can induce spasmodic muscular contractions. The most typical symptom is a muscular cramp accompanied by a sharp flash of pain. The most prevalent reasons are overexertion, dehydration, and stress. Spasms occur when a muscle moves suddenly and uncontrollably. Muscle spasms can be as minor as a twitch or as severe as a painful cramp, and they can affect muscles in any part of the body.

Muscle spasms can be relieved by stretching and gently massaging the affected area. Applying heat to the area with a warm towel, heating pad, or hot water in the shower may also be beneficial.Based on the Treatment, the market is segmented into Medication, NSAIDS, Naproxen, Ibuprofen, Piriformis Muscle Injection, Botox Injection, Steroid Injection, Physical Therapy, Acupuncture, Prolotherapy, Osteopathic Manipulative Treatment (OMT), Surgery, and Others. Medication segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2026-2032. Ibuprofen and other over-the-counter anti-inflammatory drugs can help reduce swelling and pain. Your doctor may inject straight into the piriformis muscle in some circumstances. The spasm and pain can be relieved with a topical anaesthetic and corticosteroid.

Physical Therapy segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2026-2032. Following a piriformis syndrome diagnosis, the patient should be advised to refrain from the offending activities and begin physical therapy treatment. When combined with stretching and manual therapy, physical therapy modalities are frequently useful types of treatment.

Based on the End-User, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others. Hospitals & Clinics segment is expected to hold the largest market shares of xx% by 2032. This is due to the growing number of the piriformis syndrome patients increases the number of treatments of piriformis syndrome in the hospitals & clinics. This is the key driver that is expected to drives the growth of this segment in the market during the forecast period.

Piriformis Syndrome Market Regional Insights:

North America region is expected to dominate the Piriformis Syndrome market during the forecast period 2026-2032. North America region is expected to hold the largest market shares of xx% by 2032. Because of its well-established healthcare system, rising healthcare expenditures, growing awareness of the syndrome, and growing senior population, the North American region is expected to dominate the market. Furthermore, the North America market growth is driven by a significant concentration of prominent hospitals in this region's developed countries, as well as favourable reimbursement rates. Also, a big number of well-known firms in the United States are expected to contribute to the piriformis syndrome market's faster growth in this region.

Europe region is expected to grow rapidly at a CAGR of xx% during the forecast period 2026-2032. The market is expected to be driven by government assistance for research and development expenditures, as well as an increase in secondary lifestyle in the Europe region. Furthermore, countries such as Germany and France are leading the market growth in Europe.

The objective of the report is to present a comprehensive analysis of the Global Piriformis Syndrome Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also help in understanding the Global Piriformis Syndrome Market dynamic, structure by analyzing the market segments and project the Global Piriformis Syndrome Market size. Clear representation of competitive analysis of key players by Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Piriformis Syndrome Market make the report investor’s guide.

Piriformis Syndrome Market Scope: Inquire before buying

Piriformis Syndrome Market, by Region

• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)

key players / competitors profiles covered in the Piriformis Syndrome Market report in strategic perspective

Bayer AG
Novartis AG
AstraZeneca
Endo Pharmaceuticals
Teva Pharmaceuticals
Omron Healthcare
Sanofi S.A.
DePuy Synthes Companies
Miracle Stretch, LLC
Flex Pharma, Inc.
Nidd valley medical
SEIRIN Corporation
Medtronic
Johnson & Johnson
Sun Pharmaceutical Industries
Mylan N.V.
Pfizer Inc.
GlaxoSmithKline plc
Abbott Laboratories
Smith & Nephew
Zimmer Biomet
Stryker Corporation
NuVasive
Amedica Corporation
Orthofix Medical Inc.
Integra LifeSciences
Spinal Elements
Cerapedics
RTI Surgical
B. Braun Melsungen AG